We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+22.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$68.5B
AUM Growth
+$9.41B
Cap. Flow
-$1.48B
Cap. Flow %
-2.16%
Top 10 Hldgs %
11.5%
Holding
2,417
New
97
Increased
651
Reduced
820
Closed
64

Top Buys

Rank Stock Value
1
DFS
Discover Financial Services
DFS
+$613M
2
VTRS icon
Viatris
VTRS
+$608M
3
HON icon
Honeywell
HON
+$605M
4
PFGC icon
Performance Food Group
PFGC
+$166M
5
LYFT icon
Lyft
LYFT
+$162M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$694M
2
BNY
Bank of New York Mellon
BNY
+$668M
3
MRSH
Marsh
MRSH
+$609M
4
DIS icon
Walt Disney
DIS
+$140M
5
TFC icon
Truist Financial
TFC
+$128M

Sector Composition

Rank Sector Weight
1 Technology 18.62%
2 Healthcare 15.47%
3 Financials 13.03%
4 Industrials 11.38%
5 Consumer Discretionary 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INFN
2076
DELISTED
Infinera Corporation Common Stock
INFN
$33K ﹤0.01%
3,138
– –
ABR icon
2077
Arbor Realty Trust
ABR
$960M
$32K ﹤0.01%
2,224
– –
CENT icon
2078
Central Garden & Pet Co
CENT
$2.74B
$32K ﹤0.01%
1,038
– –
FORR icon
2079
Forrester Research
FORR
$172M
$32K ﹤0.01%
760
– –
INBK icon
2080
First Internet Bancorp
INBK
$231M
$32K ﹤0.01%
+1,100
New +$26.4K
VRTS icon
2081
Virtus Investment Partners
VRTS
$1.11B
$32K ﹤0.01%
148
– –
RDUS
2082
DELISTED
Radius Health, Inc.
RDUS
$32K ﹤0.01%
1,799
– –
LMNX
2083
DELISTED
Luminex Corp
LMNX
$32K ﹤0.01%
1,395
– –
ASTE icon
2084
Astec Industries
ASTE
$1.3B
$31K ﹤0.01%
543
– –
CYRX icon
2085
CryoPort
CYRX
$775M
$31K ﹤0.01%
701
-27,489
-98% -$1.31M
EAF icon
2086
GrafTech
EAF
$194M
$31K ﹤0.01%
295
– –
PJT icon
2087
PJT Partners
PJT
$4.37B
$31K ﹤0.01%
412
– –
SMCI icon
2088
Super Micro Computer
SMCI
$19.5B
$31K ﹤0.01%
9,640
– –
EGRX
2089
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$31K ﹤0.01%
668
– –
SRNE
2090
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$31K ﹤0.01%
4,593
– –
BEAM icon
2091
Beam Therapeutics
BEAM
$2.58B
$30K ﹤0.01%
365
– –
BTAI icon
2092
BioXcel Therapeutics
BTAI
$26.2M
$29K ﹤0.01%
39
– –
CBZ icon
2093
CBIZ
CBZ
$2.29B
$29K ﹤0.01%
1,081
– –
COKE icon
2094
Coca-Cola Consolidated
COKE
$12.3B
$29K ﹤0.01%
1,090
– –
NNI icon
2095
Nelnet
NNI
$4.79B
$29K ﹤0.01%
410
– –
PETS icon
2096
PetMed Express
PETS
$42.5M
$29K ﹤0.01%
907
– –
USNA icon
2097
Usana Health Sciences
USNA
$394M
$29K ﹤0.01%
371
– –
YMAB
2098
DELISTED
Y-mAbs Therapeutics
YMAB
$29K ﹤0.01%
595
– –
ALEC icon
2099
Alector
ALEC
$164M
$28K ﹤0.01%
1,854
– –
MRTN icon
2100
Marten Transport
MRTN
$1.33B
$28K ﹤0.01%
1,651
– –
82 83
84
85 86

Similar funds

AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Macquarie Group's Q4 2020 Portfolio in Review

As of Q4 2020, Macquarie Group held 2,417 positions worth $68.5B, up 16% from $59.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group's Q4 2020 filing shows 97 new, 651 increased, 820 reduced and 64 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M. The largest sale was Pfizer, an estimated $694M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Macquarie Group's largest Q4 2020 buy was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M.
  • Macquarie Group added most to Discover Financial Services in Q4 2020, an estimated $613M increase.
  • Macquarie Group's biggest Q4 2020 reduction was Pfizer, cutting an estimated $694M.
  • Macquarie Group fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $64.8M.
  • Macquarie Group's ten largest holdings make up 11% of its $68.5B portfolio in Q4 2020.
  • Macquarie Group opened 97 new positions and closed 64 in Q4 2020.
  • Macquarie Group's portfolio value rose 16% quarter-over-quarter to $68.5B.

Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.